Aquestive Therapeutics, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United States

Last price 3.89 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 488.24M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Aquestive Therapeutics, Inc. operates as a pharmaceutical company in the United States and internationally. It offers Libervant, a buccal soluble film formulation of diazepam for the treatment of seizures; Suboxone, a sublingual film formulation of buprenorphine and naloxone for the treatment of opioid dependence; EMYLIF, an oral film formulation of riluzole; ONDIF, an oral soluble film formulation of ondansetron; SYMPAZAN, an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form o...